Research Grants 37 show all


$2.2M
2015

$903.5K
2016

$984.7K
2017

$674.9K
2018

$1M
2019

Patents 341show all

  • 116
    C12Q - Measuring or testing processes involving enzymes, nucleic acids or microorganisms
  • 78
    C12N - Microorganisms or enzymes
  • 19
    A61K - Preparations for medical, dental, or toilet purposes
  • 19
    C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture
  • 6
    C07K - Peptides
  • 6
    G01N - Investigating or analysing materials by determining their chemical or physical properties
  • 6
    G16B - Bioinformatics, i.e. information and communication technology [ict] specially adapted for genetic or protein-related data processing in computational molecular biology
  • 5
    C07C - Acyclic or carbocyclic compounds
  • 2
    G16H - Healthcare informatics, i.e. information and communication technology [ict] specially adapted for the handling or processing of medical or healthcare data
  • 1
    B65H - Handling thin or filamentary material, e.g. sheets, webs, cables

Clinical Trials 1show all

SEC Filings show all


3
D

Contact Information

Louisburg, MO
United States

SEC Form D Funding Events

DateOfferedSoldType
2013-03-20$15,000,000$7,500,000Equity
2011-08-11$10,000,000$5,000,000Equity
2007-11-19Unknown Unknown Other (Paper Filing)

Key Executives

  • Matthew M Winkler
    Executive Officer, Director
  • Rolland Carlson
    Executive Officer, Director
  • Christopher D Earl
    Director
  • Evan S Melrose
    Director
  • John E Mooney
    Director
  • Lyle Arnold
    Director
  • Robert J Dominici
    Director
  • David Sargent
    Director
  • Lynne Hohlfeld
    Executive Officer
  • Ana Ward
    Executive Officer
  • Carol Berry
    Executive Officer
  • David Rubin
    Director